Octreotide lessens peritoneal injury in experimental encapsulated peritoneal sclerosis model

ERTILAV M., HUR E., Bozkurt D. , SIPAHI S., TİMUR O., SARSIK B. , ...Daha Fazla

NEPHROLOGY, cilt.16, ss.552-557, 2011 (SCI İndekslerine Giren Dergi) identifier identifier identifier


Aim: Encapsulated peritoneal sclerosis is characterized by neoangiogenesis and fibrosis. Octreotide, a somatostatin analogue is a well-known antifibrotic, antiproliferative and anti-angiogenic agent. The aim of the study is to evaluate the effects of octreotide in encapsulated peritoneal sclerosis-induced neoangiogenesis and fibrosis and compare the results with resting.